glp-1 sleep apnea Efficacy of Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes GLP-1s may help some patients

22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide

The GLP-1 receptor agonist market is experiencing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, and the high...

Over the past year, more patients have come to us asking about Ozempic (semaglutide) and similar GLP-1 receptor agonists for their role in weight loss but also for effects on []

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

Get the details at ADW Diabetes.